Solid Tumors
Showing 76 - 100 of >10,000
Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)
Recruiting
- Solid Tumor
- EGFR Amplification
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Cancer Trial in L'Hospitalet de Llobregat (MBF-362)
Recruiting
- Cancer
-
L'Hospitalet de Llobregat, Barcelona, SpainInstituto Catalan de OncologĂa
Jul 7, 2023
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
Solid Tumors Trial in Waratah (IBI334)
Not yet recruiting
- Solid Tumors
-
Waratah, New South Wales, AustraliaWestmead Hospital
Mar 7, 2023
Registry Study in MSI/dMMR Solid Tumors
Not yet recruiting
- DMMR Cancer
- +2 more
- (no location specified)
Aug 21, 2023
Malignant Solid Tumors Trial (T60c injection)
Not yet recruiting
- Malignant Solid Tumors
- T60c injection
- (no location specified)
Oct 7, 2023
Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I
Not yet recruiting
- Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
- Phase I dose escalation
- +3 more
-
Shanghai, Shanghai, ChinaFudan Cancer Hospital
Apr 24, 2023
Advanced Solid Tumors Trial in Chuo-ku (MEDI5752)
Active, not recruiting
- Advanced Solid Tumors
- MEDI5752
-
Chuo-ku, JapanResearch Site
Jan 19, 2023
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
Advanced Solid Tumor Trial in Shanghai (HS-10386)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Jun 20, 2023
Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)
Not yet recruiting
- Colorectal Cancer
- Solid Tumors
- (no location specified)
Feb 15, 2023
Advanced Solid Tumor Trial in Guangzhou (YL201 for Injection)
Recruiting
- Advanced Solid Tumor
- YL201 for Injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 21, 2023
Advanced Solid Tumors Trial in Beijing (LY010616)
Enrolling by invitation
- Advanced Solid Tumors
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
May 9, 2023
Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive
Not yet recruiting
- Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
- Non-investigational
- (no location specified)
May 11, 2023
NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- +4 more
- MK-2870
- +2 more
- (no location specified)
Sep 15, 2023
Advanced Solid Tumors Trial in Tianjin (KM501)
Not yet recruiting
- Advanced Solid Tumors
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital
Apr 5, 2023
Malignant Solid Tumors Trial (2.5-3.5mCi 64Cu-FAPI-XT117, 3.5-4.5mCi 64Cu-FAPI-XT117, 4.5-5.5mCi 64Cu-FAPI-XT117)
Not yet recruiting
- Malignant Solid Tumors
- 2.5-3.5mCi 64Cu-FAPI-XT117
- +2 more
- (no location specified)
Jul 7, 2023
Malignant Tumor Trial in Beijing (NV-001)
Not yet recruiting
- Malignant Neoplasm
- NV-001
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 21, 2023
MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)
Not yet recruiting
- MTAP-null Non-Small-Cell Lung Cancer
- MTAP-null Solid Tumors
- AMG 193
- IDE397
- (no location specified)
Jul 27, 2023